GBA1 and Parkinson disease: In PD patients with heterozygous glucocerebrosidase (GBA) mutations (GBA-PD), Cavallieri and co-workers [37] found that allopregnanolone levels correlated with a more severe motor impairment, and they were negatively correlated with cognitive dysfunction.